SAFETY AND EFFECTIVENESS OF LAGB IN PATIENTS AT THE EDGES (BMI<35, BMI>50, AGE<18, AGE>60)
Παρουσιάστηκε στο 3rd Congress of the International Federation for the Surgery of Obesity(Europeam Chapter), Capri, Italy Apr 17-19, 2008
Δημοσιεύθηκε ως περίληψη στο Obesity Surgery 2008:18;452
BACKGROUND: LAGB is a worldwide popular bariatric procedure. Current selection criteria do not include patients with BMI<35, age<18, age >65 and is not strongly recommended for patients with BMI>50. We studied the safety and effectiveness of LAGB in these groups of patients based on papers presented in the last 3 IFSO world congresses. Our experience was also evaluated.
METHODS: All related papers presented in the last 3 IFSO world congresses (Maastricht. Sydney, Porto) were included. Each study needed to report complications, adequate follow-up and outcome regarding weight loss. Our patients were also assessed.
RESULTS: A total of 19 papers met the entry criteria (3 studies with BMI<35, 9 with BMI>50, 4 with age<18 and 3 with advanced age). In our series of 1065 patients (April 2004-Nov 2007), 113(10%) were found to have BMI<35, 202(19%) with BMI>50, 19(1.8%) patients aged<18 and 20 patients(2%) aged>65. There was no mortality reported. Slippage and band migration were the most common complications reported in all groups of patients. Patients were followed-up for a mean period of 5 years (range 1-7 years). Mean percentage of EWL was 67% after 1.8 years for patients with BMI<35, 54% after 4.7 years with BMI>50, 52% after 2.5 years with age<18 and 54% after 2 years with advanced age. Similar results were found in our patients as well.
CONCLUSION: LAGB is a safe, easy to perform, reversible and effective bariatric procedure. With additional studies, demonstrating long-term effectiveness of LAGB, it is reasonable to expect the selection criteria for bariatric surgery to be altered.
δείτε την παρουσίαση
MEDIA
DIGITAL MEDIA STUDIO
